#ndaq — Public Fediverse posts on home.social

Germany @[email protected] · 2026-06-23 · 13:30 UTC

Silexion Therapeutics Receives Approval from Germany’s

CTA Approval from Germany’s Federal Institute for Drugs and Medical Devices (BfArM), accompanied by a positive opinion from…
#Germany #DE #Europe #EU #Europa #Biotech #BiotechStocks #KRAS #nasdaq #Nasdaq:SLXN #NDAQ:SLXN #Oncology #Pharma #PrecisionMedicine #PrecisionOncology #SilexionTherapeuticsCorp #SLXN #SLXNW #XNAS:SLXN
https://www.europesays.com/germany/41862/

#xnas #slxnw #slxn #silexiontherapeuticscorp #precisiononcology #precisionmedicine

Alo Japan @[email protected] · 2026-02-04 · 14:46 UTC

https://www.alojapan.com/1449915/nasdaq-tech-picked-for-osaka-exchange-derivatives-revamp/ Nasdaq tech picked for Osaka Exchange derivatives revamp #DerivativesTrading #EqlipseTrading #JapanExchangeGroup #MarketSurveillance #Nasdaq #NDAQ #news #Osaka #OsakaExchange #OsakaNews #TechnologyPartnership #大阪 #大阪府      Nasdaq (NYSE:NDAQ) announced that Japan Exchange Group’s Osaka Exchange (OSE) selected Nasdaq’s Eqlipse Trading and Market Surveillance platforms for a next-generation derivatives infrastructure on

#derivativestrading #eqlipsetrading #japanexchangegroup #marketsurveillance #nasdaq #ndaq

Alo Japan @[email protected] · 2025-11-19 · 17:36 UTC

https://www.alojapan.com/1415348/actelis-networks-secures-new-order-for-leading-japanese/ Actelis Networks Secures New Order for Leading Japanese #$ASNS #Actelis #ActelisNetworks #Connectivity #Inc. #Japan #JapanNews #Japanese #JapaneseNews #NASDAQ:ASNS #Nasdaq:ASNS #NDAQ:ASNS #NDAQ:ASNS #news #XNAS:ASNS FREMONT, Calif, Nov. 19, 2025 (GLOBE NEWSWIRE) — Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid-deployment networking solutions for IoT and broadband applications, toda

#actelis #actelisnetworks #connectivity #inc #japan #japannews

ExTraders Global @[email protected] · 2024-04-25 · 12:54 UTC

Nasdaq Inc (#NDAQ) reported #earnings per share (EPS) of $0.63, slightly below the forecasted $0.65. However, their revenue exceeded expectations, reaching $1.117 billion compared to the forecasted $1.11361 billion. #NASDAQ

#ndaq #earnings #nasdaq